We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Blood Gas and Electrolyte Analyzers Market to Be Dominated by Portable/Hand-Held Automated Devices

By LabMedica International staff writers
Posted on 11 Jul 2022
Print article
Image: The global blood gas and electrolyte analyzers market will surpass USD 3 billion by 2026 (Photo courtesy of Pexels)
Image: The global blood gas and electrolyte analyzers market will surpass USD 3 billion by 2026 (Photo courtesy of Pexels)

Blood gas and electrolyte analyzers are used to check for a variety of disorders in the bloodstream. Blood gas analyzers measure partial pressure of oxygen in a patient’s blood while electrolyte analyzers measure the concentration of vital elements such as sodium, potassium, and calcium. These popular diagnostic devices uses along with other tests help in accurate diagnosis of various chronic conditions such as asthma, chronic obstructive pulmonary disease (COPD), kidney failure, heart failure, uncontrolled diabetes, severe infections, and drug overdose. The global blood gas and electrolyte analyzers market is projected to register a CAGR of 9% from USD 1.7 billion in 2017 to over USD 3 billion by 2026, driven by the growing preference for portable or hand-held automated analyzers.

These are the latest findings of Transparency Market Research (Wilmington, DE, USA), a global market research company.

Currently, technological advancements, an increase in chronic illnesses and a rising elderly population are driving the growth of the global blood gas and electrolyte analyzers market. Advanced analyzers have reduced turnaround time and enhance patient care by providing accurate results. Going forward, advanced analyzers with reduced turnover time and enhanced efficiency and productivity are expected to drive the demand for blood gas and electrolyte analyzers over the next few years. The global market is expected to be further driven by an increase in the number of patients treated in NICUs, ICUs, and emergency departments, as well as a rise in patients battling various chronic illnesses. Increased investments in healthcare by governments around the world are also expected to contribute to the growth of the global blood gas and electrolyte analyzers market. However, the shortage of skilled health care professionals in the developing regions for operating advanced blood gas analysis devices and the complexities associated in interpreting blood analysis results is likely to hamper market growth.

Based on product type, the combination analyzers segment held a majority of share of the global blood gas and electrolyte analyzers market in terms of revenue in 2017. The paradigm shift from traditional central laboratory blood gas analyzers to point-of-care testing devices and rise in demand for multi-parameter monitoring are expected to propel the growth of the combination analyzers segment. Based on region, North America accounted for the largest share of the global blood gas and analyzers market in 2017, followed by Europe. North America is expected to maintain its dominant position due to its well-developed healthcare industry and the existence of top blood gas and electrolyte analyzer producers in the region, while the increased adoption of advanced technologies and large geriatric population in Germany will propel the growth of the market in Europe.

The market for blood gas and electrolyte analyzers in Asia Pacific is likely to offer significant growth opportunities, owing to rising awareness about blood disorders and procedures for employing these analyzers, increasing incidence of chronic diseases and greater need for testing analyzers in newly constructed hospitals in the region, and increased focus of key players in its emerging markets such as China and India.

Related Links:
Transparency Market Research 

HLX
New
Gold Supplier
CLIA Analyzer
VIRCLIA
New
Incubation & Imaging System
BD KiestraReadA
New
Auto Clinical Chemistry Analyzer
ChemiLab 100

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more

Microbiology

view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more

Pathology

view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.